26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

primary tumor 593 private specificity<br />

primary tumor<br />

The original neoplasm arising from the first transformed cell.<br />

primate (nonhuman) immune system<br />

Nonhuman primates represent the best animal models of<br />

many human diseases based on the resemblance of their<br />

immune system to that of humans. Lymphocyte subsets<br />

of human and nonhuman primates have been shown to be<br />

similar through the use of leukocyte-specific monoclonal<br />

antibodies. Similarities also exist between human and nonhuman<br />

primate major histocompatibility complex (MHC)<br />

and T cell receptor (TCR) genes.<br />

prime boost strategy<br />

A vaccination protocol requiring primary vaccination with a<br />

recombinant vector or naked DNA vaccine with a subsequent<br />

booster injection of a recombinant protein subunit vaccine.<br />

primed<br />

A lymphoid cell or an intact animal exposed once to a<br />

specific antigen that mounts a rapid and heightened response<br />

upon second exposure to the same antigen. Products of the<br />

reaction may be manifested as increased antibody production<br />

or heightened cell-mediated immunity against the antigen.<br />

primed lymphocyte<br />

A lymphocyte that has interacted with an antigen in vivo or<br />

in vitro.<br />

primed lymphocyte test (PLT)<br />

Lymphocytes previously exposed or primed to a certain<br />

antigen in a primary mixed lymphocyte culture divide<br />

rapidly when re-exposed to the same antigen. Using a<br />

primed cell, one can determine whether an unknown cell<br />

possesses the original stimulating antigen. Cells previously<br />

exposed to major histocompatibility complex (MHC)<br />

class II human leukocyte antigens (HLAs) can be used in<br />

HLA typing for HLA-D region antigens. PLT is an assay<br />

for the detection of lymphocyte-associated determinants<br />

(LADs). Lymphocytes donated by a normal person can<br />

serve as responder cells against the antigens of a known cell<br />

type. The test is based on the secondary stimulation of the<br />

primed or sensitized lymphocytes. The original stimulator<br />

serves as a positive control. The response of the sensitized<br />

cell to other cells measured by the incorporation of tritiated<br />

thymidine, by comparison with the control, may suggest<br />

sharing of HLA-D-associated antigens with the original<br />

stimulator cell if high stimulation values result. The HTC<br />

typing procedure, on the other hand, implies an antigenic<br />

determinant shared between the two cell types when there<br />

is little or no response. PLT is a positive typing procedure<br />

and has the advantage that homozygous donor cells are not<br />

required. Primed or sensitized cells can be prepared and<br />

frozen for future use when needed. They can be used to<br />

type unknowns within 24 hours which eliminates the 5 to 6<br />

days necessary for a homozygous cell-typing procedure.<br />

primed lymphocyte typing (PLT)<br />

A method to type for HLA-D antigenic determinants. It<br />

is a type of mixed lymphocyte reaction in which cells<br />

previously exposed to allogeneic lymphocytes of known<br />

specificity can be re-exposed to unknown lymphocytes to<br />

determine their HLA-DP type, for example.<br />

priming<br />

The activation of antigen-specific naïve lymphocytes<br />

following exposure to antigen in an immunogenic form.<br />

Primed lymphocytes develop into either armed effector<br />

cells or into memory cells capable of responding rapidly to<br />

a second exposure to an antigen. The initial interaction of<br />

a naïve lymphocyte with a specific epitope that produces a<br />

primary immune response.<br />

priming dose<br />

The initial dose of an immunogen administered to an animal<br />

for the purpose of inducing an immune response.<br />

Prion.<br />

prion<br />

An infectious particle comprised of a protein with appended<br />

carbohydrate. It is the most diminutive infectious agent<br />

known. The three human diseases in which prions have<br />

been implicated include kuru, Creutzfeldt–Jakob disease,<br />

and Gerstmann–Straussler syndrome. Prions have also<br />

been implicated in animal diseases such as sheep and goat<br />

scrapie, bovine spongiform encephalopathy, chronic wasting<br />

of elk and mule deer, and transmissible mink encephalopathy.<br />

Prions do not induce inflammation or stimulate<br />

antibody synthesis. They resist formalin, heat, ultraviolet<br />

radiation, and other agents that normally inactivate viruses.<br />

They possess a 28-kDa, hydrophobic glycoprotein particle<br />

that polymerizes, forming an amyloid-like fibrillar structure.<br />

Prions produce disease by changing the conformation of<br />

their normal protein counterparts in the infected host brain.<br />

PRIST<br />

Abbreviation for paper radioimmunosorbent test, a technique<br />

used to assay serum IgE levels. It resembles the<br />

radioimmunoabsorbent test except that filter paper discs<br />

impregnated with anti-human IgE are used in place of<br />

Sephadex ® discs.<br />

private antigen<br />

(1) An antigen confined to one major histocompatibility<br />

complex (MHC) molecule. (2) An antigenic specificity<br />

restricted to a few individuals. (3) A tumor antigen restricted<br />

to a specific chemically induced tumor. (4) A low-frequency<br />

epitope present on red blood cells of fewer than 0.1% of the<br />

population (Pt a , By, Bp a , etc.). (5) Human leukocyte antigen<br />

(HLA) encoded by one allele such as HLA-B27.<br />

private idiotypic determinant<br />

A determinant produced by a particular amino acid<br />

sequence in the immunoglobulin heavy or light chain<br />

hypervariable region of an antibody synthesized by only<br />

one individual.<br />

private specificity<br />

An epitope found on a protein encoded by a single allele;<br />

thus, it is found only on one member of a group of proteins,<br />

such as alloantigens of the major histocompatibility<br />

complex (MHC), even though it may also apply to other<br />

alloantigenic systems.<br />

P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!